Livtencity (MARIBAVIR)
200 mg/1 · Coated Tablet
By Takeda Pharmaceuticals America, Inc.
- NDC
- 64764-800
- Route
- Oral
- Therapeutic class
- Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytomegalovirus pUL97 Kinase Inhibitor , Cytomegalovirus pUL97 Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 1 BOTTLE in 1 CARTON (64764-800-28) / 28 TABLET, COATED in 1 BOTTLENDC 64764-800-28Available to order
- 1 BOTTLE in 1 CARTON (64764-800-56) / 56 TABLET, COATED in 1 BOTTLENDC 64764-800-56Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Vitamins & Supplements
See all →
GUNA-ARTHRO
Solution / Drops
Guna spa
Available to source

GUNA-DIZZY
Solution / Drops
Guna spa
Available to source

Se-Natal 19
30 mg/1 / 1000 [iU]/1 +13 · Tablet
Seton Pharmaceuticals
Available to source
Resource Essentials Sun Protection Mineral SPF 30 (14% Zinc Oxide)
24.78 g/177g · Spray
Skinresource.md, L.L.C.
Available to source
